30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 2 CLINICAL PHARMACOKINETICS<br />

Neal MJ 2005 Medical pharmacology at a glance, 5th edn. Blackwell,<br />

Oxford<br />

Pratt WB (ed.) 1990 Principles of drug action: the basis of<br />

pharmacology, 3rd edn. Churchill Livingstone, New York<br />

Rowland M, Tozer TN 1995 <strong>Clinical</strong> pharmacokinetics: concepts and<br />

applications, 3rd edn. Williams and Wilkins, Baltimore, MD<br />

Speight TM, Holford NHG (eds) 1997 Avery’s drug treatment: a guide to<br />

properties, choice, therapeutic use and economic value of drugs in<br />

disease management, 4th edn. Adis International, Auckland,<br />

New Zealand<br />

Walsh CT, Schwartz-Bloom RD 2005 Levine’s pharmacology: drug<br />

actions and reactions, 7th edn. Taylor and Francis, London<br />

APPENDIX: PHARMACOKINETIC EQUATIONS FOR CALCULATING PARAMETERS<br />

FROM DOSE ADMINISTRATION EXPERIMENTS<br />

In order to determine the pharmacokinetic parameters<br />

of a drug, experiments are conducted whereby subjects<br />

are given a drug, and blood samples are collected at<br />

various time points after administration. The concentration<br />

of the drug in plasma is then measured. By plotting<br />

concentration versus time, several important parameters<br />

can be derived that help determine, for example, the<br />

dosing regimen for a drug. Some undergraduate veterinary<br />

courses require students to perform these types of<br />

calculations and postgraduate students may also need<br />

to be able to assess such data. Therefore basic methods<br />

for calculating various pharmacokinetic parameters are<br />

given below.<br />

• Plot the natural logarithm of plasma concentrations<br />

against time on linear graph paper or plot plasma<br />

concentrations against time on semilog paper.<br />

• If the plot is linear then the area under the curve<br />

(AUC) can be calculated using equation 3 below. If<br />

the plot is not linear, AUC can only be calculated<br />

using either differential calculus or the trapezoid<br />

method (see Fig. 2.2). An exponential decline in drug<br />

concentration is described by first-order kinetics and<br />

assumes a single compartment model (i.e. the drug<br />

appears to be in one compartment in the body or<br />

immediately distributed to all compartments).<br />

• The rate at which the concentration declines is<br />

described by the constant λ (which is the slope at the<br />

change in concentration when concentration is<br />

plotted as natural logs).<br />

• The concentration at any time is related to the<br />

maximum concentration by the equation:<br />

C t = C max·e −λt<br />

If the plot is not linear (e.g. concave curve initially<br />

then becomes linear) this indicates that the drug has not<br />

been distributed to the tissues instantly, i.e. there are<br />

two (or more compartments), and this can be solved<br />

with a biexponential equation which is beyond the<br />

scope of this chapter. Assuming there is a linear plot<br />

from when the dose is given (time 0 for IV or complete,<br />

rapid IM injections or after rapid absorption or after<br />

infusion turned off):<br />

1. Elimination half-life (t 1/2 )<br />

Calculate t 1/2 from the graph (time it takes for<br />

a concentration anywhere along the graph to<br />

halve).<br />

12<br />

10<br />

C max<br />

T 1 T 2C1<br />

t 1 /2 = T 2 –T 1<br />

= In2/t 1 /2<br />

Drug concentration<br />

8<br />

6<br />

4<br />

T max<br />

1/2 C 1<br />

2<br />

0<br />

0 1 2 3 4 5 6<br />

Time<br />

7 8 9 10 11 12<br />

Fig. 2.2 Estimation of area under the curve: trapezoidal rule. Observed drug concentration is plotted against time<br />

after oral administration of a drug formulation. Key features of this graph include: C max (maximum concentration<br />

observed); T max (time at which maximum concentration observed); elimination half-life (t 1/2 ) (time for concentration to<br />

halve, i.e. fall from C 1 to 1/2C 1 ): elimination rate l (rate of change of concentration).<br />

38

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!